Antifungal Medicated Bar
- Manufacturer
- RoyceDerm LLC
- Effective date
- 2025-03-25
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 00:59:23
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Tolnaftate 1%
OTC - PURPOSE SECTION
anti-fungal
INDICATIONS & USAGE SECTION
- Cures & prevents most athlete's foot(tinea pedis), jock itch(tinea cruris) & ringworm (tinea corporis).
- Relieves itching, irritation, redness, scaling, and discomfort associated with these conditions.
WARNINGS SECTION
For external use only
OTC - DO NOT USE SECTION
on children under 2 years of age except under the advice and supervision of a doctor.
OTC - WHEN USING SECTION
avoid contact with the eyes. If contact occurs, rinse the eyes thoroughly with water.
OTC - STOP USE SECTION
if condition worsens or does not improve after 4 weeks of regular use as directed.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
If swallowed, get medical help or contact a Poison Control Center right away.
DOSAGE & ADMINISTRATION SECTION
- Wash the affected area thoroughly with water.
- Lather the soap and apply it to the affected area.
- Allow the lather to sit on the skin for 2-3 minutes before rinsing thoroughly.
- For athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily.
- Use 1-2 times daily for 4 weeks; if the condition persists longer, consult a doctor.
- Supervise children in the use of this product.
OTHER SAFETY INFORMATION
- Store at room temperature.
- Protect from freezing.
INACTIVE INGREDIENT SECTION
Melaleuca Alternifolia (Tea Tree) Leaf Oil, Aqua (Water), Sorbitol, Elaeis Guineensis (Palm) Oil, Cocos Nucifera (Coconut) Oil, Olea Europaea (Olive) Fruit Oil, Propylene Glycol, Glycerin, Stearic Acid, Lauric Acid, Myristic Acid, Sodium Myristate, Sodium Glutamate, Sodium Hydroxide, Sodium Dodecylbenzene Sulfonate, Sulfur, Hamamelis Virginiana (Witch Hazel) Extract, Ceramide NP.
OTC - QUESTIONS SECTION
Visit at
www.roycederm.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed RxNorm Mappings#
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 85424-001-01 | Antifungal Medicated Bar | 232 g in 1 CARTON | SOAP | 232 | 1 |
DailyMed Dashboard NDC Coverage#
Products#
Every source-derived product name is available through these pages.
- Antifungal Medicated Bar
- Tolnaftate
- SODIUM HYDROXIDE
- GLYCERIN
- SODIUM DODECYLBENZENESULFONATE
- MELALEUCA ALTERNIFOLIA (TEA TREE) LEAF OIL
- ELAEIS GUINEENSIS (PALM) OIL
- LAURIC ACID
- SODIUM GLUTAMATE
- PROPYLENE GLYCOL
- SODIUM MYRISTATE
- MYRISTIC ACID
- STEARIC ACID
- HAMAMELIS VIRGINIANA (WITCH HAZEL) LEAF WATER
- SORBITOL
- OLEA EUROPAEA (OLIVE) FRUIT OIL
- COCOS NUCIFERA (COCONUT) OIL
- WATER
- CERAMIDE NP
- SULFUR
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 85424-001 | 85424-001-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Antifungal Medicated Bar | TOLNAFTATE | RoyceDerm LLC | 31305ed2-a0a0-6d4c-e063-6294a90a6ba5 | 2025-03-25 | Warnings | 85424-001-01 85424-001 85424000101 31305ed2-a0a1-6d4c-e063-6294a90a6ba5 31305ed2-a0a0-6d4c-e063-6294a90a6ba5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
